AKEBIA THERAPEUTICS, INC. (AKBA) Operating cash flow 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$68.0MFY2025 · since FY2016: $57.9M → $68.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $68.0M | +267.2% |
| FY2024 | -$40.7M | -73.9% |
| FY2023 | -$23.4M | +68.0% |
| FY2022 | -$73.2M | +71.1% |
| FY2021 | -$253.0M | -129.2% |
| FY2020 | -$110.4M | +57.1% |
| FY2019 | -$257.4M | -164.1% |
| FY2018 | -$97.5M | -73.6% |
| FY2017 | -$56.2M | -197.0% |
| FY2016 | $57.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AKBA financial trends
AKBA RevenueAKBA Net incomeAKBA Net marginAKBA Gross profitAKBA Gross marginAKBA Operating incomeAKBA Operating marginAKBA Free cash flowAKBA Capital expendituresAKBA Return on equityAKBA Stock buybacksAKBA Dividends paidAKBA Total assetsAKBA Total liabilitiesAKBA Shareholders’ equityAKBA overview →